Levosulpiride

Levosulpiride
Clinical data
Trade names	Dislep, Sulpepta, others
Other names	L-Sulpiride; S-(–)-Sulpiride; RV-12309
Routes of; administration	Oral
ATC code	N05AL07 (WHO) ;
Identifiers
	IUPAC name N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide;
CAS Number	23672-07-3;
PubChem CID	688272;
IUPHAR/BPS	958;
DrugBank	DB16021;
ChemSpider	599749;
UNII	JTG7R315LK;
KEGG	D07312;
ChEBI	CHEBI:64119;
ChEMBL	ChEMBL267044;
CompTox Dashboard (EPA)	DTXSID0042583;
Chemical and physical data
Formula	C15H23N3O4S
Molar mass	341.43 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC;
	InChI InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1; Key:BGRJTUBHPOOWDU-NSHDSACASA-N;
	(verify)

Levosulpiride, sold under the brand names Dislep and Sulpepta among others, is a dopamine antagonist medication which is used in the treatment of psychotic disorders like schizophrenia, major depressive disorder, nausea and vomiting, and gastroparesis. It is taken by mouth.

Levosulpiride is marketed widely throughout the world, including in Europe, South Korea, Latin America, India, and Pakistan. It is not available in the United States or the United Kingdom.